γ-Hydroxybutyrate is a weak agonist at recombinant GABA(B) receptors

Neuropharmacology

Volumn 38, Issue 11, 1999, Pages 1667-1673

  Lingenhoehl, Kurt ^a   Brom, Richard ^a   Heid, Jakob ^a   Beck, Pascal ^a   Froestl, Wolfgang ^a   Kaupmann, Klemens ^a   Bettler, Bernhard ^a   Mosbacher, Johannes ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Electrophysiology; GABA(B) receptor; Gamma aminobutyrate; Gamma hydroxybutyrate; Xenopus oocytes

Indexed keywords

2 HYDROXYSACLOFEN; 3 AMINOPROPYL(DIETHOXYMETHYL)PHOSPHINIC ACID; 3N [1 (3,4 DICHLOROPHENYL)ETHYLAMINO] 2 HYDROXYPROPYL]CYCLOHEXYLMETHYLPHOSPHINIC ACID; 4 (3 AMINOPROPYL) 4 DIETHOXYMETHYLPHOSPHINIC ACID; 4 AMINOBUTYRIC ACID B RECEPTOR; 4 HYDROXYBUTYRIC ACID; 6,7,8,9 TETRAHYDRO 5H CYCLOHEPTEN 5 OL 4 YLIDENEACETIC ACID; BACLOFEN; CGP 5462A; CGP 64213; ETHOSUXIMIDE; NSC 382; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG; VALPROIC ACID;

ANIMAL CELL; ARTICLE; CELL STRAIN COS1; CONTROLLED STUDY; DRUG RECEPTOR BINDING; IN VITRO STUDY; NEUROTRANSMISSION; NONHUMAN; OOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; XENOPUS;

ANESTHETICS, INTRAVENOUS; ANIMALS; GABA ANTAGONISTS; MEMBRANE POTENTIALS; RATS; RECEPTORS, GABA-B; SODIUM OXYBATE; XENOPUS;

EID: 0032820954     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(99)00131-8     Document Type: Article

References (32)

1. B) receptor-mediated release of GABA and glutamate (GLU) in rat thalamic ventrobasal nucleus (VB): a possible mechanism for the generation of absence-like seizures induced by GHB. Journal of Pharmacology and Experimental Therapeutics. 273:1995;1534-1543.
2. Benavides J., Rumigny J.F., Bourguignon J.J. et al. High affinity binding sites for gamma-hydroxybutyric acid in rat brain. Life Science. 30:1982;953-961.
3. Cash C.D. Gamma-hydroxybutyrate: an overview of the pros and cons for it being a neurotransmitter and/or a useful therapeutic agent. Neuroscience and Biobehavioral Review. 18:1994;291-304.
4. Diana M., Mereu G., Mura A., Fadda F., Passino N., Gessa G. Low doses of gamma-hydroxybutyric acid stimulate the firing rate of dopaminergic neurons in unanesthetized rats. Brain Research. 566:1991;208-211.
5. B receptors. Neuroscience Letters. 216:1996;121-124.
6. B-receptors. Naunyn-Schmiedeberg's Archives of Pharmacology. 348:1993;491-497.
7. B receptors. Naunyn-Schmiedeberg's Archives of Pharmacology. 357:1998;611-619.
8. Feigenbaum J.J., Howard S.G. Gamma-hydroxybutyrate is not a GABA agonist. Progess in Neurobiology. 50:1996;1-7.
9. Galloway G.P., Frederick S.L., Staggers Jr F.E., Gonzales M., Stalcup S.A., Smith D.E. Gamma-hydroxybutyrate: an emerging drug of abuse that causes physical dependence. Addiction. 92:1997;89-96.
10. Godbout R., Jelenic P., Labrie C., Schmitt M., Bourguignon J.J. Effect of gamma-hydroxybutyrate and its antagonist NCS-382 on spontaneous cell firing in the prefrontal cortex of the rat. Brain Research. 673:1995;157-160.
11. Hechler V., Gobaille S., Maitre M. Selective distribution pattern of gamma-hydroxybutyrate receptors in the rat forebrain and midbrain as revealed by quantitative autoradiography. Brain Research. 572:1992;345-348.
12. B binding that is blocked by valproate and ethosuximide. Journal of Pharmacology and Experimental Therapeutics. 281:1997;753-760.
13. + channel is important for channel activation. Neuron. 15:1995;1133-1143.
14. BR2. Nature. 396:1998;674-679.
15. B receptors uncovers similarity to metabotropic glutamate receptors. Nature. 386:1997;239-246.
16. B-receptor subtypes assemble into functional heteromeric complexes. Nature. 396:1998;683-687.
17. Kemmel V., Taleb O., Perard A. et al. Neurochemical and electrophysiological evidence for the existence of a functional gamma-hydroxybutyrate system in NCB-20 neurons. Neuroscience. 86:1998;989-1000.
18. B receptor function. Science. 283:1999;74-77.
19. Leff P., Dougall I.G. Further concerns over Cheng-Prusoff analysis. Trends in Pharmacological Science. 14:1993;110-112.
20. B receptor agonist that increases a potassium conductance in rat ventral tegmental dopamine neurons. Journal of Pharmacology and Experimental Therapeutics. 287:1998;261-265.
21. Maitre M. The gamma-hydroxybutyrate signalling system in brain: organization and functional implications. Progress in Neurobiology. 51:1997;337-361.
22. B receptor agonist. European Journal of Pharmacology. 321:1997;67-75.
23. Mosbacher J., Maier R., Fakler B., Glatz A., Crespo J., Bilbe G. P2Y receptor subtypes differentially couple to inwardly-rectifying potassium channels. FEBS Letters. 436:1998;104-110.
24. Olpe H.R., Koella W.P. Inhibition of nigral and neocortical cells by gamma-hydroxybutyrate: a microiontophoretic investigation. European Journal of Pharmacology. 53:1979;359-364.
25. Snead III O.C., Liu C.C. Gamma-hydroxybutyric acid binding sites in rat and human brain synaptosomal membranes. Biochemical Pharmacology. 33:1984;2587-2590.
26. Snead III O.C., Furner R., Liu C.C. In vivo conversion of gamma-aminobutyric acid and 1,4-butanediol to gamma-hydroxybutyric acid in rat brain. Studies using stable isotopes. Biochemical Pharmacology. 38:1989;4375-4380.
27. Snead III O.C. The gamma-hydroxybutyrate model of absence seizures: correlation of regional brain levels of gamma-hydroxybutyric acid and gamma-butyrolactone with spike wave discharges. Neuropharmacology. 30:1991;161-167.
28. Vayer P., Charlier B., Mandel P., Maitre M. Effect of anticonvulsant drugs on gamma-hydroxybutyrate release from hippocampal slices: inhibition by valproate and ethosuximide. Journal of Neurochemistry. 49:1987;1022-1024.
29. Waldmeier P.C. The GABAB antagonist, CGP35348, antagonizes the effects of baclofen, gamma-butyrolactone and HA 966 on rat striatal dopamine synthesis. Naunyn-Schmiedeberg's Archives of Pharmacology. 343:1991;173-178.
30. B receptor. Nature. 396:1998;679-682.
31. B receptor-mediated hyperpolarization. Neuroscience. 66:1995;133-141.
32. B receptors. European Journal of Pharmacology. 212:1992;291-294.